Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights | BioSpace

[ad_1] WALTHAM, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients…